Transient elastography-based liver profiles in a hospital-based pediatric population in Japan

PLoS ONE

Volumn 10, Issue 9, 2015, Pages

  Cho, Yuki ^a   Tokuhara, Daisuke ^a   Morikawa, Hiroyasu ^a   Kuwae, Yuko ^a   Hayashi, Eri ^b   Hirose, Masakazu ^a   Hamazaki, Takashi ^a   Tanaka, Akemi ^a   Kawamura, Tomoyuki ^a   Kawada, Norifumi ^a   Shintaku, Haruo ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Izumi Municipal Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADOLESCENT OBESITY; AGE DISTRIBUTION; ARTICLE; BODY MASS; CHILD; CHILDHOOD OBESITY; CONTROLLED ATTENUATION PARAMETER; CONTROLLED STUDY; DIGESTIVE TRACT PARAMETERS; DISEASE ASSOCIATION; ELASTOGRAPH; ELASTOGRAPHY; FATTY LIVER; FEASIBILITY STUDY; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; JAPAN; JAPANESE (PEOPLE); LIVER DISEASE; LIVER EXAMINATION; LIVER FIBROSIS; LIVER STIFFNESS MEASUREMENT; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; SEX DIFFERENCE; BLOOD; DIAGNOSTIC IMAGING; INFANT; LIVER; LIVER CIRRHOSIS; OBESITY; PATHOLOGY; PRESCHOOL CHILD;

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; TRIACYLGLYCEROL;

ADIPOSITY; ADOLESCENT; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; CHILD; CHILD, PRESCHOOL; ELASTICITY IMAGING TECHNIQUES; FATTY LIVER; FEMALE; HUMANS; INFANT; JAPAN; LIVER; LIVER CIRRHOSIS; MALE; PEDIATRIC OBESITY; TRIGLYCERIDES;

EID: 84946935127     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0137239     Document Type: Article

References (44)

1. Takeda T, Yasuda T, Nakayama Y, Nakaya M, Kimura M, Yamashita M, et al. Usefulness of noninvasive transient elastography for assessment of liver fibrosis stage in chronic hepatitis C. World J Gastroenterol. 2006; 12: 7768-7773. PMID: 17203518
2. Kawamoto M, Mizuguchi T, Katsuramaki T, Nagayama M, Oshima H, Kawasaki H, et al. Assessment of liver fibrosis by a noninvasive method of transient elastography and biochemical markers. World J Gastroenterol. 2006; 12: 4325-4330. PMID: 16865773
3. Sandrin L, Fourquet B, Hasquenoph JM, Yon S, Fournier C, Mal F, et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol. 2003; 29: 1705-1713. PMID: 14698338
4. Myers RP, Pollett A, Kirsch R, Pomier-Layrargues G, Beaton M, Levstik M, et al. Controlled attenuation parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography. Liver Int. 2012; 32: 902-910. doi: 10.1111/j.1478-3231.2012.02781.x PMID: 22435761
5. Sasso M, Tengher-Barna I, Ziol M, Miette V, Fournier C, Sandrin L, et al. Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan: validation in chronic hepatitis C. J Viral Hepat. 2012; 19: 244-253. doi: 10.1111/j.1365-2893.2011.01534.x PMID: 22404722
6. de Lédinghen V, Vergniol J, Foucher J, Merrouche W, le Bail B. Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography. Liver Int. 2012; 32: 911-918. doi: 10.1111/j.1478-3231.2012.02820.x PMID: 22672642
7. Goyal R, Mallick SR, Mahanta M, Kedia S, Shalimar, Dhingra R, et al. Fibroscan can avoid liver biopsy in Indian patients with chronic hepatitis B. J Gastroenterol Hepatol. 2013; 28: 1738-1745. doi: 10.1111/jgh.12318 PMID: 23808910
8. Kim SU, Jang HW, Cheong JY, Kim JK, Lee MH, Kim DJ, et al. The usefulness of liver stiffness measurement using FibroScan in chronic hepatitis C in South Korea: a multicenter, prospective study. J Gastroenterol Hepatol. 2011; 26: 171-178. doi: 10.1111/j.1440-1746.2010.06385.x PMID: 21175811
9. Sánchez Antolin G, Garcia Pajares F, Vallecillo MA, Fernandez Orcajo P, Gómez de la Cuesta S, Alcaide N, et al. FibroScan evaluation of liver fibrosis in liver transplantation. Transplant Proc. 2009; 41: 1044-1046. doi: 10.1016/j.transproceed.2009.02.027 PMID: 19376422
10. Friedrich-Rust M, Hadji-Hosseini H, Kriener S, Herrmann E, Sircar I, Kau A, et al. Transient elastography with a new probe for obese patients for non-invasive staging of non-alcoholic steatohepatitis. Eur Radiol. 2010; 20: 2390-2396. doi: 10.1007/s00330-010-1820-9 PMID: 20526777
11. de Lédinghen V, Vergniol J, Capdepont M, Chermak F, Hiriart JB, Cassinotto C, et al. Controlled attenuation parameter (CAP) for the diagnosis of steatosis: a prospective study of 5323 examinations. J Hepatol. 2014; 60: 1026-1031. doi: 10.1016/j.jhep.2013.12.018 PMID: 24378529
12. Goldschmidt I, Streckenbach C, Dingemann C, Pfister ED, di Nanni A, Zapf A, et al. Application and limitations of transient liver elastography in children. J Pediatr Gastroenterol Nutr. 2013; 57: 109-113. doi:10.1097/MPG.0b013e31829206a0 PMID: 23539048
13. de Lédinghen V, Le Bail B, Rebouissoux L, Fournier C, Foucher J, Miette V, et al. Liver stiffness measurement in children using FibroScan: feasibility study and comparison with Fibrotest, aspartate transaminase to platelets ratio index, and liver biopsy. J Pediatr Gastroenterol Nutr. 2007; 45: 443-450. PMID: 18030211
14. Engelmann G, Gebhardt C, Wenning D, Wühl E, Hoffmann GF, Selmi B, et al. Feasibility study and control values of transient elastography in healthy children. Eur J Pediatr. 2012; 171: 353-60. doi: 10.1007/s00431-011-1558-7 PMID: 21861093
15. Alkhouri N, Sedki E, Alisi A, Lopez R, Pinzani M, Feldstein AE, et al. Combined paediatric NAFLD fibrosis index and transient elastography to predict clinically significant fibrosis in children with fatty liver disease. Liver Int. 2013; 33: 79-85. doi: 10.1111/liv.12024 PMID: 23146095
16. Lee CK, Perez-Atayde AR, Mitchell PD, Raza R, Afdhal NH, Jonas MM. Serum biomarkers and transient elastography as predictors of advanced liver fibrosis in a United States cohort: the Boston Children's Hospital experience. J Pediatr. 2013; 163: 1058-1064. doi: 10.1016/j.jpeds.2013.04.044 PMID: 23759423
17. Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology. 2006; 43: S99-S112. PMID: 16447287
18. Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, Contreras M, et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology. 2011; 140: 124-131. doi: 10.1053/j.gastro.2010.09.038 PMID: 20858492
19. Loomba R, Sirlin CB, Schwimmer JB, Lavine JE. Advances in pediatric nonalcoholic fatty liver disease. Hepatology. 2009; 50: 1282-1293. doi: 10.1002/hep.23119 PMID: 19637286
20. Tominaga K, Kurata JH, Chen YK, Fujimoto E, Miyagawa S, Abe I, et al. Prevalence of fatty liver in Japanese children and relationship to obesity. An epidemiological ultrasonographic survey. Dig Dis Sci. 1995; 40: 2002-2009. PMID: 7555456
21. Schwimmer JB, Deutsch R, Kahen T, Lavine JE, Stanley C, Behling C. Prevalence of fatty liver in children and adolescents. Pediatrics. 2006; 118: 1388-1393. PMID: 17015527
22. Strauss RS, Barlow SE, Dietz WH. Prevalence of abnormal serum aminotransferase values in overweight and obese adolescents. J Pediatr. 2000; 136: 727-733. PMID: 10839867
23. Park HS, Han JH, Choi KM, Kim SM. Relation between elevated serum alanine aminotransferase and metabolic syndrome in Korean adolescents. Am J Clin Nutr. 2005; 82: 1046-1051. PMID: 16280437
24. Sartorio A, Del Col A, Agosti F, Mazzilli G, Bellentani S, Tiribelli C, et al. Predictors of non-alcoholic fatty liver disease in obese children. Eur J Clin Nutr. 2007; 61: 877-883. PMID: 17151586
25. Ekstedt M, Franzén LE, Mathiesen UL, Thorelius L, Holmqvist M, Bodemar G, et al. Long-term followup of patients with NAFLD and elevated liver enzymes. Hepatology. 2006; 44: 865-873. PMID: 17006923
26. Vajro P, Lenta S, Socha P, Dhawan A, McKiernan P, Baumann U, et al. Diagnosis of nonalcoholic fatty liver disease in children and adolescents: position paper of the ESPGHAN Hepatology Committee. J Pediatr Gastroenterol Nutr. 2012; 54: 700-713. doi: 10.1097/MPG.0b013e318252a13f PMID: 22395188
27. Feldstein AE, Charatcharoenwitthaya P, Treeprasertsuk S, Benson JT, Enders FB,Angulo P. The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years. Gut. 2009; 58: 1538-1544. doi: 10.1136/gut.2008.171280 PMID: 19625277
28. Molleston JP, White F, Teckman J, Fitzgerald JF. Obese children with steatohepatitis can develop cirrhosis in childhood. Am J Gastroenterol. 2002; 97: 2460-2462. PMID: 12358273
29. Lebensztejn DM, Skiba E, Sobaniec-Lotowska M, Kaczmarski M. A simple noninvasive index (APRI) predicts advanced liver fibrosis in children with chronic hepatitis B. Hepatology. 2005; 41: 1434-1435. PMID: 15915470
30. Forns X, Ampurdanès S, Llovet JM, Aponte J, Quintó L, Martínez-Bauer E, et al. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology. 2002; 36: 986-992. PMID: 12297848
31. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005; 41: 1313-1321. PMID: 15915461
32. Millonig G, Friedrich S, Adolf S, Fonouni H, Golriz M, Mehrabi A, Stiefel P, Pöschl G, Büchler MW, Seitz HK, Mueller S. Liver stiffness is directly influenced by central venous pressure. J Hepatol. 2010; 52: 206-10. doi: 10.1016/j.jhep.2009.11.018 PMID: 20022130
33. Mueller S, Millonig G, Sarovska L, Friedrich S, Reimann FM, Pritsch M, Eisele S, Stickel F, Longerich T, Schirmacher P, Seitz HK. Increased liver stiffness in alcoholic liver disease: differentiating fibrosis from steatohepatitis. World J Gastroenterol. 2010; 16: 966-72. PMID: 20180235
34. Ratziu V, Giral P, Charlotte F, Bruckert E, Thibault V, Theodorou I, et al. Liver fibrosis in overweight patients. Gastroenterology. 2000; 118: 1117-1123. PMID: 10833486
35. Mofrad P, Contos MJ, Haque M, Sargeant C, Fisher RA, Luketic VA, et al. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. Hepatology. 2003; 37: 1286-1292. PMID: 12774006
36. Kunde SS, Lazenby AJ, Clements RH, Abrams GA. Spectrum of NAFLD and diagnostic implications of the proposed new normal range for serum ALT in obese women. Hepatology. 2005; 42: 650-656. PMID: 16037946
37. Roulot D, Czernichow S, Le Clesiau H, Costes J, Vergnaud A, Beaugrand M. Liver stiffness values in apparently healthy subjects: influence of gender and metabolic syndrome. J Hepatol. 2008; 48: 606-613. doi: 10.1016/j.jhep.2007.11.020 PMID: 18222014
38. Wong GL, Wong VW, Chim AM, Yiu KK, Chu SH, Li MK, et al. Factors associated with unreliable liver stiffness measurement and its failure with transient elastography in the Chinese population. J Gastroenterol Hepatol. 2011; 26: 300-305. doi: 10.1111/j.1440-1746.2010.06510.x PMID: 21261720
39. Needleman L, Kurtz AB, Rifkin MD, Cooper HS, Pasto ME, Goldberg BB. Sonography of diffuse benign liver disease: accuracy of pattern recognition and grading. Am J Roentgenol. 1986; 146: 1011-1015.
40. Saverymuttu SH, Joseph AE, Maxwell JD. Ultrasound scanning in the detection of hepatic fibrosis and steatosis. Br Med J. (Clin Res Ed). 1986; 292: 13-15.
41. Pacifico L, Celestre M, Anania C, Paolantonio P, Chiesa C, Laghi A. MRI and ultrasound for hepatic fat quantification: relationships to clinical and metabolic characteristics of pediatric nonalcoholic fatty liver disease. Acta Paediatr. 2007; 96: 542-547. PMID: 17306008
42. Bohte AE, van Werven JR, Bipat S, Stoker J. The diagnostic accuracy of US, CT, MRI, and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis. Eur Radiol. 2011; 21: 87-97. doi: 10.1007/s00330-010-1905-5 PMID: 20680289
43. Lewin M, Poujol-Robert A, Boëlle PY, Wendum D, Lasnier E, Viallon M. Diffusion-weighted magnetic resonance imaging for the assessment of fibrosis in chronic hepatitis C. Hepatology. 2007; 46: 658-665. PMID: 17663420
44. Ohtomo K, Baron RL, Dodd GD 3rd, Federle MP, Miller WJ, Campbell WL. Confluent hepatic fibrosis in advanced cirrhosis: appearance at CT. Radiology. 1993; 188: 31-5. PMID: 8511316